183 related articles for article (PubMed ID: 9255152)
21. Breast imaging with fluorine-18-FDG PET: quantitative image analysis.
Avril N; Bense S; Ziegler SI; Dose J; Weber W; Laubenbacher C; Römer W; Jänicke F; Schwaiger M
J Nucl Med; 1997 Aug; 38(8):1186-91. PubMed ID: 9255146
[TBL] [Abstract][Full Text] [Related]
22. Castleman's Disease of the Kidney Mimicking Renal Cell Carcinoma on FDG PET/CT.
Wang Y; Dong A; Yang B; Lu J
Clin Nucl Med; 2018 May; 43(5):e160-e163. PubMed ID: 29432340
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma.
el-Shirbiny AM; Yeung H; Imbriaco M; Michaeli J; Macapinlac H; Larson SM
J Nucl Med; 1997 Aug; 38(8):1208-10. PubMed ID: 9255151
[TBL] [Abstract][Full Text] [Related]
24. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma.
Nieweg OE; Pruim J; van Ginkel RJ; Hoekstra HJ; Paans AM; Molenaar WM; Koops HS; Vaalburg W
J Nucl Med; 1996 Feb; 37(2):257-61. PubMed ID: 8667056
[TBL] [Abstract][Full Text] [Related]
25. Ectopic lacrimal gland of the orbit.
Sakurai H; Mitsuhashi N; Hayakawa K; Nozaki M; Kurosaki H; Kishi S; Joshita T; Niibe H
J Nucl Med; 1997 Sep; 38(9):1498-500. PubMed ID: 9293818
[TBL] [Abstract][Full Text] [Related]
26. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.
Leskinen-Kallio S; Ruotsalainen U; Någren K; Teräs M; Joensuu H
J Nucl Med; 1991 Jun; 32(6):1211-8. PubMed ID: 2045935
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
[TBL] [Abstract][Full Text] [Related]
28. Retroperitoneal Castleman's disease presenting with hydronephrosis indistinguishable from lymphoma.
Kim YS; Jung MH
J Obstet Gynaecol Res; 2011 Aug; 37(8):1145-8. PubMed ID: 21501323
[TBL] [Abstract][Full Text] [Related]
29. Angiofollicular lymph node hyperplasia resembling a spinal nerve sheath tumor: a rare case of Castleman's disease.
Stevens EA; Strowd RE; Mott RT; Oaks TE; Wilson JA
Spine J; 2009 Sep; 9(9):e18-22. PubMed ID: 19482516
[TBL] [Abstract][Full Text] [Related]
30. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
[TBL] [Abstract][Full Text] [Related]
31. [Castleman's lymphoma. Differential diagnosis of mediastinal tumors].
Blum U; Beck A; Laaff H; Ortlieb H
Rofo; 1988 Jul; 149(1):57-9. PubMed ID: 2840711
[TBL] [Abstract][Full Text] [Related]
32. PET FDG studies in oncology.
Hawkins RA; Hoh CK
Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
[TBL] [Abstract][Full Text] [Related]
33. Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis.
Leisure GP; Vesselle HJ; Faulhaber PF; O'Donnell JK; Adler LP; Miraldi F
J Nucl Med Technol; 1997 Jun; 25(2):115-9. PubMed ID: 9239615
[TBL] [Abstract][Full Text] [Related]
34. A case of abdominal mesenteric Castleman's disease with left renal cell carcinoma and stomach leiomyoma.
Chen S; Song L; Xie X; Han X; Cheng B
Hell J Nucl Med; 2016; 19(3):285-288. PubMed ID: 27999828
[TBL] [Abstract][Full Text] [Related]
35. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
36. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
Okada J; Yoshikawa K; Imazeki K; Minoshima S; Uno K; Itami J; Kuyama J; Maruno H; Arimizu N
J Nucl Med; 1991 Apr; 32(4):686-91. PubMed ID: 2013808
[TBL] [Abstract][Full Text] [Related]
37. Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma.
de Wit M; Bumann D; Beyer W; Herbst K; Clausen M; Hossfeld DK
Ann Oncol; 1997; 8 Suppl 1():57-60. PubMed ID: 9187431
[TBL] [Abstract][Full Text] [Related]
38. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
Hoffman JM; Waskin HA; Schifter T; Hanson MW; Gray L; Rosenfeld S; Coleman RE
J Nucl Med; 1993 Apr; 34(4):567-75. PubMed ID: 8455072
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of pleural diseases with FDG-PET imaging: preliminary report.
Bury T; Paulus P; Dowlati A; Corhay JL; Rigo P; Radermecker MF
Thorax; 1997 Feb; 52(2):187-9. PubMed ID: 9059484
[TBL] [Abstract][Full Text] [Related]
40. PET for diagnosis of malignant lymphoma of the scalp: comparison of [11C]methyl-L-methionine and [18F]fluoro-2-deoxyglucose.
Tsuyuguchi N; Hakuba A; Okamura T; Ochi H; Suzuki T; Sunada I
J Comput Assist Tomogr; 1997; 21(4):590-3. PubMed ID: 9216763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
